Key result
ANP inhibits macrophage nitric oxide synthesis in a dose-dependent manner via NPR-A and cGMP.
Why the study?
The effects of different natriuretic peptides on nitric oxide synthesis in macrophages and the receptor mechanisms mediating these effects were not fully elucidated.
ANP inhibits NO production in LPS-activated macrophages via the NPR-A receptor and cGMP, providing mechanistic insight into its immunomodulatory effects.
No takes yet. Share an insight, caveat, or question.
ANP inhibits NO via NPR-A/cGMP in macrophage lines; leaves open in vivo immunomodulatory relevance.
Alexandra K. Kiemer (1997) studied this question. Atrial natriuretic peptide (ANP) vs. Urodilatin, atriopeptin I, C-type natriuretic peptide (CNP) was evaluated on NO synthesis (measured as nitrite accumulation). Atrial natriuretic peptide dose-dependently inhibited NO synthesis in LPS-activated macrophages via the guanylate cyclase coupled NPR-A receptor and cGMP.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: